AUTL — Autolus Therapeutics plc
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1730463 ·
Last close
$1.09
Market Cap
$290.12M
52W High
$2.58
52W Low
$1.07
ADV30
2,385,409
Next earnings
2026-11-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 41,238,000 | 23,311,000 | -43,535,000 | -55,091,000 | 523,059,000 | 245,405,000 | 495,663,000 |
| Jun 2026 | 45,689,000 | 25,221,000 | -43,838,000 | -39,111,000 | 493,226,000 | 171,414,000 | 418,387,000 |
| Mar 2026 | 26,218,000 | 1,650,000 | -59,513,000 | -71,598,000 | 527,065,000 | 130,925,000 | 418,239,000 |
| Dec 2025 | 24,289,000 | -1,041,000 | -72,469,000 | -90,332,000 | 589,068,000 | 104,132,000 | 410,939,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-176,241,000
Investing CF
$276,586,000
Financing CF
$61,325,000
CapEx
$-17,345,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.93
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,552,552,000
Inventory
$35,015,000
Receivables
$62,247,000
ST Investments
$2,972,000
EBIT TTM
$-210,661,000
Pretax Income TTM
$-256,476,000
Interest Exp TTM
$45,815,000
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$137,434,000
EBITDA
$-208,422,000
Free Cash Flow
—
Enterprise Value
$460,097,280
Total Cash
$248,376,992
Total Debt
$397,016,000
Shares Out
266,162,540
Trailing EPS
$-0.94
Book Value
$0.10
ROE
-174.9%
ROA
-23.1%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 75,388,000 | -270,544,000 | -287,528,000 | 589,068,000 | 410,939,000 | 178,129,000 | -283,568,000 |
| Dec 2024 | 10,120,000 | -241,426,000 | -220,662,000 | 782,725,000 | 355,400,000 | 427,325,000 | -206,271,000 |
| Dec 2023 | 1,698,000 | -175,528,000 | -208,383,000 | 375,381,000 | 263,907,000 | 111,474,000 | -145,587,000 |
| Dec 2022 | 6,194,000 | -142,893,000 | -148,839,000 | 490,274,000 | 191,600,000 | 298,674,000 | -112,308,000 |
TTM Snapshot
Revenues TTM
$117,390,000
NetIncome TTM
$-280,159,000
OpCashFlow TTM
—
Assets (Latest)
$493,226,000
Forward EPS
$-0.60
Max Pain — expiry 2026-12-18
max pain strike: $1.50 · spot: $1.06 · call oi: 2,686 · put oi: 65
Expected Move to 2026-12-18:
±$1.10
(103.77%) —
implied range
$-0.04 –
$2.16
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AGMB | AgomAb Therapeutics NV | $291.55M | $5.92 | — |
| KYTX | Kyverna Therapeutics, Inc. | $297.14M | $4.70 | — |
| SCTX | Scribe Therapeutics, Inc. | $298.64M | $15.77 | — |
| EDIT | Editas Medicine, Inc. | $281.67M | $1.83 | — |
| AGEN | AGENUS INC | $280.98M | $6.21 | — |
News headlines (Yahoo Finance, 1h cache)
Autolus Therapeutics Presents Longer-Term Follow Up Data from CARLYSLE Trial at the American College of Rheumatology Convergence 2026
2026-11-10 21:05 · Yahoo
Autolus Therapeutics Q3 Earnings Call Highlights
2026-11-10 15:15 · Yahoo
Autolus Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates
2026-11-10 12:00 · Yahoo
Autolus Therapeutics to Participate in the Jefferies Global Healthcare Conference
2026-11-09 12:15 · Yahoo
Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2026
2026-11-04 14:15 · Yahoo
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-11-03 21:45 · Yahoo
Autolus Therapeutics to Report Third Quarter 2026 Financial Results and Host Conference Call on November 10, 2026
2026-10-26 20:15 · Yahoo
All You Need to Know About Autolus Therapeutics (AUTL) Rating Upgrade to Buy
2026-10-05 15:00 · Yahoo
Autolus Therapeutics to Present Longer-Term Follow Up Data from CARLYSLE Trial at the American College of Rheumatology Convergence 2026
2026-10-05 12:30 · Yahoo
AUCATZYL Sales Are Exploding, But Autolus (AUTL) Still Isn’t In The Black
2026-09-12 10:21 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.